Asia Oceania Journal of Nuclear Medicine and Biology

Asia Oceania Journal of Nuclear Medicine and Biology

Multisystem FDG-avid lesions mimicking malignancy in a teenager with hyper-IgE syndrome: A case study with literature review

Document Type : Case report

Authors
Fatemeh Saboktakin
Saeed Farazanefar
Nasim Vahidfar
Shaghayegh Ranjbar
Niloofar Tabatabaeian
Department of Nuclear Medicine, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
10.22038/aojnmb.2026.91014.1671
Abstract
Hyper-IgE Syndrome (HIES) is a rare immunodeficiency predisposing patients to infections, inflammation, and occasional neoplasia. We report a 17-year-old boy with HIES who presented with severe right thigh pain. FDG-PET/CT demonstrated a right adrenal mass (SUVmax=5.4), multiple pulmonary nodules, and a lytic-sclerotic femoral lesion (SUVmax=4.6), initially suggesting disseminated malignancy. Biopsy confirmed acute osteomyelitis and a benign spindle cell tumor of the adrenal gland. Two months later, persistent fever and elevated ESR prompted re-evaluation, revealing intense FDG uptake in the thoracic aorta (SUVmax=20.5) consistent with large vessel vasculitis, later confirmed by angiography. The combination of infection, benign tumor, and vasculitis illustrates the broad FDG uptake spectrum in HIES and the risk of misdiagnosis as malignancy. Integration of clinical, imaging, and histopathologic data was critical for accurate diagnosis. This case highlights FDG-PET/CT’s value in detecting inflammatory vascular disease and monitoring therapy, while reinforcing the importance of biopsy for definitive diagnosis. In immunodeficient patients, a multimodal diagnostic approach is essential to distinguish between malignant and benign FDG-avid lesions.
Keywords
Hyper-IgE syndrome
Job's syndrome
FDG-PET
Subjects
1.       Grimbacher B, Holland SM, Puck JM. Hyper‐IgE syndromes. Immunological reviews. 2005; 203(1): 244-50. 
2.       Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007; 448(7157): 1058-62.
3.       Freeman AF, Holland SM. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes. Pediatric Research. 2009; 65(7): 32-7. 
4.       Love C, Tomas MB, Tronco GG, Palestro CJ. FDG PET of infection and inflammation. Radiographics. 2005; 25(5): 1357-68. 
5.       Zhuang H, Jian QY, Alavi A. Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiologic Clinics. 2005; 43(1):121-34.
6.       Noriega-Álvarez E, Gadea LD, Diez MO, Valgañón VP, Viedma SS, Jiménez RG. Role of Nuclear Medicine in the diagnosis of musculoskeletal infection: A review. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 2019; 38(6): 397-407.
7.       Sakellariou M, Dellaportas D, Peppa M, Schizas D, Pikoulis E, Nastos K. Review of the literature on leiomyoma and leiomyosarcoma of the adrenal gland: a systematic analysis of case reports. In vivo. 2020; 34(5): 2233-48.
8.       Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. The American journal of surgical pathology. 2007; 31(4): 509-20. 
9.       Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer. 1986; 57(10): 2006-21. 
10.   Lew DP, Waldvogel FA. Osteomyelitis. The Lancet. 2004; 364(9431):3 69-79.
11.   Zhuang H, Alavi A. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. In Seminars in Nuclear Medicine 2002; 32(1): 47-59. 
12.   Keser G, Aksu K, Direskeneli H. Takayasu arteritis: an update. Turkish Journal of Medical Sciences. . 2018; 48(4): 681-697. 
13.   Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. STAT3 mutations in the hyper-IgE syndrome. New England Journal of Medicine. 2007; 357(16): 1608-19. 
14.   Sathekge M, Maes A, Van de Wiele C. FDG-PET imaging in HIV infection and tuberculosis. InSeminars in nuclear medicine 2013; 43(5):349-366. 
15.   Watanabe K, Tajino T, Sekiguchi M, Suzuki T. h-Caldesmon as a specific marker for smooth muscle tumors: comparison with other smooth muscle markers in bone tumors. American journal of clinical pathology. 2000; 113(5): 663-8.
16.   Kumar R, Xiu Y, Yu JQ, Takalkar A, El-Haddad G, Potenta S, et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. Journal of Nuclear Medicine. 2004; 45(12): 2058-62.
17.   Durbin M, Randall RL, James M, Sudilovsky D, Zoger S. Ewing's sarcoma masquerading as osteomyelitis. Clinical Orthopaedics and Related Research®. 1998; 357: 176-85. 
18.   Sağer S, Yılmaz S, Özhan M, Halaç M, Ergül N, Çiftci H, et al. F-18 Fdg PET/CT findings of a patient with Takayasu arteritis before and after therapy. Molecular Imaging and Radionuclide Therapy. 2012; 21(1): 32.
19.   Marco DN, Gilabert R, Cid MC, Muxí A, Prieto‑González S. Hybrid 18F‑FDG‑PET with CT angiography for diagnosis of Takayasu arteritis. Rheumatology (Oxford). 2024; 63(8): e217–e218. 
Asia Oceania Journal of Nuclear Medicine and Biology
Volume 14, Issue 2
July 2026
Pages 219-223